Herantis Pharma (Finland) Price on November 14, 2024
| HRTIS Stock | EUR 1.49 0.07 4.49% |
If you're considering investing in Herantis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Herantis Pharma stands at 1.49, as last reported on the 28th of December, with the highest price reaching 1.60 and the lowest price hitting 1.45 during the day. Herantis Pharma is dangerous at the moment. Herantis Pharma Oyj holds Efficiency (Sharpe) Ratio of 0.0335, which attests that the entity had a 0.0335% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Herantis Pharma Oyj, which you can use to evaluate the volatility of the firm. Please check out Herantis Pharma's Risk Adjusted Performance of 0.0238, downside deviation of 2.53, and Market Risk Adjusted Performance of 0.8585 to validate if the risk estimate we provide is consistent with the expected return of 0.0963%.
Herantis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Herantis |
Sharpe Ratio = 0.0335
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HRTIS | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Herantis Pharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Herantis Pharma by adding it to a well-diversified portfolio.
Herantis Pharma Valuation on November 14, 2024
It is possible to determine the worth of Herantis Pharma on a given historical date. On November 14, 2024 Herantis was worth 1.25 at the beginning of the trading date compared to the closed value of 1.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Herantis Pharma stock. Still, in general, we apply an absolute valuation method to find Herantis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Herantis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Herantis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.25 | 1.26 | 1.23 | 1.25 | 5,162 | |
11/14/2024 | 1.25 | 1.25 | 1.20 | 1.24 | 27,892 |
| 1.23 | 1.23 | 1.20 | 1.20 | 6,818 |
| Backtest Herantis Pharma | | | Herantis Pharma History | | | Herantis Pharma Valuation | Previous | Next |
Herantis Pharma Trading Date Momentum on November 14, 2024
| On November 15 2024 Herantis Pharma Oyj was traded for 1.20 at the closing time. The highest price during the trading period was 1.23 and the lowest recorded bid was listed for 1.20 . The volume for the day was 6.8 K. This history from November 15, 2024 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 3.23% . The trading delta at closing time to the current price is 6.45% . |
Herantis Pharma Oyj Fundamentals Correlations and Trends
By evaluating Herantis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Herantis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Herantis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Herantis Pharma Stock history
Herantis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Herantis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Herantis Pharma Oyj will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Herantis Pharma stock prices may prove useful in developing a viable investing in Herantis Pharma
Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.
Herantis Pharma Stock Technical Analysis
Herantis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Herantis Pharma Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Herantis Pharma Oyj cannot be verified against its exchange. Please verify the symbol is currently traded on Helsinki Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Herantis Pharma December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Herantis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Herantis Pharma shares will generate the highest return on investment. By undertsting and applying Herantis Pharma stock market strength indicators, traders can identify Herantis Pharma Oyj entry and exit signals to maximize returns
Herantis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Herantis Pharma's price direction in advance. Along with the technical and fundamental analysis of Herantis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Herantis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0238 | |||
| Jensen Alpha | 0.0469 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0103 | |||
| Treynor Ratio | 0.8485 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Herantis Stock analysis
When running Herantis Pharma's price analysis, check to measure Herantis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Herantis Pharma is operating at the current time. Most of Herantis Pharma's value examination focuses on studying past and present price action to predict the probability of Herantis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Herantis Pharma's price. Additionally, you may evaluate how the addition of Herantis Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world |